The project will be submitted for funding under the Health Program, Project Call “Support for STEP-compatible projects submitted within the project ideas call in the field of health / with applicability in the health sector, organized by the Health Program Managing Authority (AMPS)”, Priority 9, “Contribution to the STEP Platform: biotechnologies and digital technologies, including associated services in the health sector”.
“Antibiotice S.A. undertakes to ensure that it has the financial capacity to provide its own contribution to both the eligible and non-eligible project expenditures, under the conditions of subsequent reimbursement/settlement of the expenses. Antibiotice S.A. undertakes, for a five-year period from the date of completion of the investment, in accordance with the state aid scheme and the provisions of Article 65 of Regulation (EU) No. 2021/1060, to maintain the investment made by covering the related operating and maintenance costs, as well as the necessary associated services, in order to ensure its financial sustainability,” the company said in its meeting notice.
Romania’s Health Ministry owns 53% in Antibiotice, while Infinity Capital Investments owns 13%, according to Bucharest Stock Exchange data.
(English version by Loredana Fratila-Cristescu)